Sarepta Therapeutics Correlations
SRPT Stock | USD 106.95 1.39 1.32% |
The correlation of Sarepta Therapeutics is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak. If the correlation is 0, the equities are not correlated; they are entirely random.
Sarepta Therapeutics Correlation With Market
Average diversification
The correlation between Sarepta Therapeutics and DJI is 0.16 (i.e., Average diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding Sarepta Therapeutics and DJI in the same portfolio, assuming nothing else is changed.
Sarepta |
Moving together with Sarepta Stock
0.75 | ILMN | Illumina | PairCorr |
0.69 | TERN | Terns Pharmaceuticals | PairCorr |
0.64 | CRNX | Crinetics Pharmaceuticals Earnings Call Today | PairCorr |
0.81 | CTMX | CytomX Therapeutics | PairCorr |
0.82 | EMBC | Embecta Corp | PairCorr |
Moving against Sarepta Stock
0.57 | OPT | Opthea Earnings Call Today | PairCorr |
0.47 | PHGE | Biomx Inc | PairCorr |
0.41 | LTRN | Lantern Pharma | PairCorr |
0.39 | GANX | Gain Therapeutics | PairCorr |
0.68 | EC | Ecopetrol SA ADR Earnings Call Today | PairCorr |
0.64 | OBI | Ondine Biomedical | PairCorr |
0.61 | T | ATT Inc Aggressive Push | PairCorr |
0.57 | KO | Coca Cola Aggressive Push | PairCorr |
Related Correlations Analysis
Click cells to compare fundamentals | Check Volatility | Backtest Portfolio |
Correlation Matchups
Over a given time period, the two securities move together when the Correlation Coefficient is positive. Conversely, the two assets move in opposite directions when the Correlation Coefficient is negative. Determining your positions' relationship to each other is valuable for analyzing and projecting your portfolio's future expected return and risk.High positive correlations
| High negative correlations
|
Risk-Adjusted Indicators
There is a big difference between Sarepta Stock performing well and Sarepta Therapeutics Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Sarepta Therapeutics' multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.Mean Deviation | Jensen Alpha | Sortino Ratio | Treynor Ratio | Semi Deviation | Expected Shortfall | Potential Upside | Value @Risk | Maximum Drawdown | ||
---|---|---|---|---|---|---|---|---|---|---|
RETA | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
MRTX | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
KRYS | 2.11 | 0.08 | 0.02 | 0.21 | 3.01 | 3.05 | 12.95 | |||
ICPT | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
PTCT | 2.24 | 0.42 | 0.18 | 0.85 | 2.03 | 6.61 | 23.75 | |||
IOVA | 2.66 | (0.64) | 0.00 | (0.75) | 0.00 | 4.99 | 19.16 | |||
MDGL | 2.51 | 0.07 | 0.02 | 0.08 | 3.52 | 5.28 | 15.92 | |||
VKTX | 3.23 | (0.73) | 0.00 | (1.12) | 0.00 | 4.89 | 24.65 | |||
HEPA | 7.54 | (1.27) | 0.00 | 0.56 | 0.00 | 17.65 | 86.86 |
Sarepta Therapeutics Corporate Management
Ryan JD | General VP | Profile | |
Will Tilton | Head VP | Profile | |
Joseph Bratica | Controller VP | Profile | |
William Ciambrone | Ex Operations | Profile | |
Dallan Murray | Executive Officer | Profile |